Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates.

about

Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates.

Item

http://www.wikidata.org/entity/Q41218646

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Young Israeli women with epith ...... tions and clinical correlates.

@en

type

Item

label

Young Israeli women with epith ...... tions and clinical correlates.

@en

prefLabel

Young Israeli women with epith ...... tions and clinical correlates.

@en

P1476

Young Israeli women with epith ...... ations and clinical correlates

@en

P2093

Eitan Friedman

http://www.w3.org/2001/XMLSchema#string

Gilad Ben-Baruch

http://www.w3.org/2001/XMLSchema#string

Jacob Korach

http://www.w3.org/2001/XMLSchema#string

Limor Helpman

http://www.w3.org/2001/XMLSchema#string

Omri Zidan

http://www.w3.org/2001/XMLSchema#string

Sarit Kalfon

http://www.w3.org/2001/XMLSchema#string

Tamar Perri

http://www.w3.org/2001/XMLSchema#string

P2860

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.

Characterization of BRCA1 and BRCA2 mutations in a large United States sample

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population.

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.

Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population

Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer

P304

e61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3802/JGO.2017.28.E61

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28657222

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

Israel

P932

5540720

http://www.w3.org/2001/XMLSchema#string